FDA Drug/Biologics Approval BLA 125557 S-013, BLINATUMOMAB

FDA Drug/Biologics Approval BLA 125557 S-013, BLINATUMOMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125557 S-013
Company: AMGEN
Drug Name: BLINCYTO
Active Ingredients: BLINATUMOMAB
Strength: 35MCG
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 12/03/2014
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details